By Greg Stohr
June 20 (Bloomberg) -- The U.S. Supreme Court refused to hear an appeal by Life Technologies Corp., letting Enzo Biochem Inc. press ahead with a patent infringement suit over a way to detect genetic sequences and diagnose human diseases, including cancer.
The justices today left intact a federal appeals court ruling that revived two Enzo patents invalidated by a trial court. Life Technologies and its Applera unit argued unsuccessfully that the patents weren’t specific enough in their description of the claimed invention.
Life Technologies, based in Carlsbad, California, has said the two patents are expired, so the lawsuit won’t have any effect on current products. New York-based Enzo and Yale University are seeking royalties in their lawsuit.
The case is Applera v. Enzo Biochem, 10-426.